SAN DIEGO, April 26, 2017 /PRNewswire/ -- Mesa Biotech, Inc. announced today that it has appointed Steven Sepulveda as Vice President of Global Business Development and Channel Management. Mr. Sepulveda will be responsible for developing and executing Mesa Biotech's global commercial strategy for current and future products. "We are very pleased to have Steve join our team," said Hong Cai, Co-founder and Chief Executive Officer of Mesa Biotech. "Steve brings a wealth of experience in the molecular diagnostics industry and has a proven track record of success in building and managing high-performing commercial teams. His expertise will be invaluable as we expand our global reach and bring our innovative molecular diagnostic platform to market." Prior to joining Mesa Biotech, Mr. Sepulveda served as Vice President of Global Commercial Operations at GenMark Diagnostics, where he was responsible for building and leading the global sales, marketing, and customer support organizations. He also held senior commercial roles at Roche Diagnostics and Abbott Laboratories. "I am excited to join Mesa Biotech at this pivotal time in the company's growth," said Mr. Sepulveda. "Mesa Biotech's platform has the potential to revolutionize the molecular diagnostics industry, and I am committed to helping the company achieve its full potential." About Mesa Biotech, Inc. Mesa Biotech is developing an affordable, easy-to-use, molecular diagnostic testing platform designed specifically for point-of-care (POC) settings. The platform utilizes proprietary technology that enables rapid and accurate detection of a variety of infectious diseases. Mesa Biotech's platform is currently under development and is not yet available for commercial use. To learn more about Mesa Biotech, please visit http://www.mesabiotech.com. To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/mesa-biotech-hires-steven-sepulveda-to-head-global-business-development-and-channel-management-300454780.html SOURCE Mesa Biotech, Inc.